Biosimilars and Biobetters: More than Generic Biologicals

27 April 2015
Available Seats:

Learning Objectives:

● Define biosimilars and biobetters.
● Identify at least two (2) key differences in the development of biosimilars/ biobetters compared to the innovator product.
● List at least two (2) challenges to clinical supplies for studies supporting biosimilar/ biobetter development


Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.